IAP
BIIB icon

Indie Asset Partners’s Biogen BIIB Stock Holding History

Indie Asset Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,449
Closed -$305K – 113
2022
Q1 		$305K Sell
1,449
-205
-12% -$44.6K 0.23% 81
2021
Q4 		$397K Buy
1,654
+50
+3% +$12.9K 0.29% 70
2021
Q3 		$454K Sell
1,604
-25
-2% -$8.19K 0.37% 58
2021
Q2 		$564K Sell
1,629
-50
-3% -$15.1K 0.46% 47
2021
Q1 		$470K Buy
1,679
+530
+46% +$143K 0.53% 54
2020
Q4 		$281K Buy
+1,149
New +$296K 0.33% 76

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Indie Asset Partners's BIIB Position: Q2 2022 in Review

Indie Asset Partners sold out of Biogen (BIIB) in Q2 2022, closing a stake of 1,449 shares — an estimated $305K sold.

Indie Asset Partners first reported a position in BIIB in Q4 2020 and held it in 6 quarters. The position peaked at $564K in Q2 2021. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Indie Asset Partners reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Indie Asset Partners sold 1,449 Biogen shares in Q2 2022, an estimated $305K.
  • Indie Asset Partners first reported a position in Biogen in Q4 2020 and held it in 6 quarters.
  • Indie Asset Partners's Biogen position peaked at $564K in Q2 2021.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Indie Asset Partners's 13F filing for Q2 2022, filed 12 Aug 2022.